Сравнение эффективности микроимпульсной коагуляции при центральной серозной хориоретинопатии и осложненной куполообразной макуле

Abstract

The purpose of the study was to evaluate the effectiveness of micropulse subthreshold laser coagulation (SML) in patients with complicated form of sclerogenic macular degeneration (SMD), acute and chronic central serous chorioretinopathy (CSR). Material and methods. SML was performed in 3 groups of patients. Group 1 – 15 patients with SMD from 28 to 63 years old, median age 55.0 (40; 62) years. Group 2 with acute CSR – 16 patients from 21 to 51 years old, median age – 37.0 (32; 42.5) years. Group 3 of patients with chronic CSR consisted of 15 people from 26 to 56 years old, the median age was 43.0 (40; 51). In group 1, women prevailed (93%), in groups 2 and 3 – men (94% and 80%, respectively). SML was performed with a diode laser (810 nm) in a subthreshold mode, a 10% microimpulse was used, 2-3 sessions were performed with an interval of 2-4 months. The observation period was 6-12 months. The criterion of efficiency was the complete disappearance of the liquid. Results. In group 1 of patients, serous retinal detachment (SRD) completely adhered in 7 out of 15 people (46.7%), there were no relapses during the year of follow-up. In group 2, the treatment effect was achieved in 11 out of 16 people (68.8%), 3 relapses of SRD. In group 3 with chronic CSR, complete regression of SRD was achieved in 10 out of 15 people (66.7%) with 1 recurrence of SRD. Significant dynamics of BCVA and retinal thickness in the central zone were observed only in the group with acute CSR. Conclusions. SML accelerates the resorption of subretinal fluid as efficiently as possible in patients with acute CSR. In the other two groups, this method of treatment cannot be considered completely satisfactory due to the very slow rate of regression of SRD and the absence of a significant effect on visual acuity. Key words: central serous chorioretinopathy, dome-shaped macula, sclerogenic macular degeneration, subthreshold laser micropulse coagulation.